Publications by the researcher in collaboration with Miguel A. López Pérez (48)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  2. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

2022

  1. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  2. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis

    Nature Reviews Endocrinology, Vol. 17, Núm. 12, pp. 745-755

  2. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner

    Redox Biology, Vol. 41

2020

  1. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

2019

  1. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

2018

  1. p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Current Understanding of the Hypothalamic Ghrelin Pathways Inducing Appetite and Adiposity

    Trends in Neurosciences, Vol. 40, Núm. 3, pp. 167-180

2016

  1. Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone–induced liver damage through inflammation and endoplasmic reticulum stress

    Hepatology, Vol. 64, Núm. 4, pp. 1086-1104

  2. Pharmacological and genetic manipulation of p53 in brown fat at adult but not embryonic stages regulates thermogenesis and body weight in male mice

    Endocrinology, Vol. 157, Núm. 7, pp. 2735-2749

  3. Uroguanylin action in the brain reduces weight gain in obese mice via different efferent autonomic pathways

    Diabetes, Vol. 65, Núm. 2, pp. 421-432

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

  2. Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance

    Molecular Metabolism, Vol. 4, Núm. 12, pp. 961-970

2014

  1. Hypothalamic effects of thyroid hormones on metabolism

    Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 28, Núm. 5, pp. 703-712

  2. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors

    Molecular and Cellular Endocrinology, Vol. 383, Núm. 1-2, pp. 159-169